CALCIFIED TISSUE INTERNATIONAL is a leading peer-reviewed journal published by Springer, dedicated to advancing our understanding of calcified tissues in relation to their physiological roles, pathophysiology, and therapeutic applications. With an impressive impact factor reflective of its importance in the field, this journal performs a crucial role in disseminating high-quality research that spans multiple disciplines, including Endocrinology, Orthopedics, and Sports Medicine. The journal is highly regarded within its respective categories, achieving Q1 rankings in Orthopedics and Sports Medicine, and demonstrating its commitment to excellence in scientific inquiry. While the journal operates under a traditional subscription model, it remains accessible to researchers and practitioners who seek to stay informed on the latest advancements and innovations in the study of calcified tissues. Established in 1973, CALCIFIED TISSUE INTERNATIONAL continues to be a vital resource for researchers, healthcare professionals, and students keen on exploring the intricate relationships between calcification processes and human health.

JOURNAL OF CLINICAL DENSITOMETRY, published by ELSEVIER SCIENCE INC, stands as a pivotal platform for the dissemination of cutting-edge research in the fields of endocrinology, orthopedics, and radiology. With an ISSN of 1094-6950 and an E-ISSN of 1559-0747, this journal supports the academic community with vital insights and advancements in clinical densitometry since its inception in 1998. The journal is recognized within the medical community, boasting impressive rankings such as Q3 in Endocrinology, Diabetes, and Metabolism, and Q2 in both Orthopedics and Sports Medicine and Radiology, Nuclear Medicine, and Imaging for 2023. These accolades underscore its significance as a valuable resource for researchers, healthcare professionals, and students aiming to advance their knowledge and practice in these critical areas. While it is not an Open Access publication, the journal provides vital contributions to the literature, emphasizing the importance of evidence-based approaches in clinical settings.

Therapeutic Advances in Musculoskeletal Disease is a premier, peer-reviewed journal published by SAGE Publications Ltd, focusing on the latest advancements in the understanding and treatment of musculoskeletal disorders. Since becoming an Open Access journal in 2019, it has significantly broadened its reach, providing researchers, clinicians, and practitioners with unfettered access to high-quality studies and reviews from 2009 to 2024. With an impressive impact factor reflected by its Q1 rank in Orthopedics and Sports Medicine and Q2 rank in Rheumatology for 2023, the journal occupies a critical position within its field. Ranked #31 out of 321 in Orthopedics and Sports Medicine and #17 out of 73 in Rheumatology on Scopus, it emphasizes both the clinical and scientific aspects of musculoskeletal health. This journal serves as a vital resource for advancing knowledge, encouraging collaboration, and fostering innovative treatment methods within the musculoskeletal community.

Modern Rheumatology is a premier journal dedicated to advancing the field of rheumatology through high-quality peer-reviewed research. Published by Oxford University Press, this journal reflects the latest developments in rheumatologic medicine, catering to researchers, clinicians, and students alike. With an H-Index highlighting its scholarly impact, Modern Rheumatology occupies a notable position, ranking Q2 in both the fields of Medicine and Rheumatology in 2023, and is listed among the top 25 journals in its category by Scopus. Spanning from the year 2000 to 2024, the journal features a diverse array of topics aimed at addressing current challenges and innovations in the field. Although it does not offer Open Access, it provides essential insights for professionals seeking to stay abreast of evolving treatment modalities and research breakthroughs. Located in the heart of the United Kingdom, Modern Rheumatology is a vital resource for anyone committed to enhancing the understanding and treatment of rheumatic diseases.

Current Opinion in Endocrinology, Diabetes and Obesity, published by LIPPINCOTT WILLIAMS & WILKINS, offers a critical analysis of the latest advancements and trends in the fields of endocrinology, diabetes, and obesity. With an ISSN of 1752-296X and an E-ISSN of 1752-2978, this esteemed journal provides an authoritative platform for researchers, clinicians, and healthcare professionals to stay updated on emerging research and clinical practices. Renowned for its impactful contributions, the journal holds notable rankings, including Q2 in Endocrinology and Diabetes & Metabolism, as well as a commendable Q1 in Internal Medicine, reflecting its significance in the academic community. Although currently not an open access publication, articles published from 2007 to 2024 continually enrich the discourse on pressing health issues related to endocrinology and metabolic disorders. By fostering a comprehensive understanding of the complexities within these interconnected fields, it serves as an essential resource for any professional or student engaged in health science research.

The Journal of Bone and Mineral Research, published by Wiley, is a leading international journal dedicated to advancing the understanding of skeletal biology and bone health since its inception in 1986. With a strong focus on the intersection of endocrinology, diabetes, metabolism, and orthopedics and sports medicine, this journal holds a prestigious Q1 ranking in both fields for 2023, highlighting its significant impact and relevance in the scientific community. The journal attracts high-quality research, as evidenced by its Scopus ranking—7th in Orthopedics and Sports Medicine and 25th in Endocrinology. This makes it a vital resource for researchers, clinicians, and students keen on exploring the intricacies of bone metabolism and disorders. While the journal operates on a subscription basis, it remains committed to disseminating pivotal research and fostering innovations that enhance bone health worldwide.

Turk Osteoporoz Dergisi - Turkish Journal of Osteoporosis, published by GALENOS PUBL HOUSE, is a vital resource for researchers and practitioners in the field of endocrinology, diabetes, and metabolism, with a specific focus on osteoporosis. Since its inception as an open-access journal in 2002, it serves to disseminate significant findings and advancements in osteoporosis research, enabling wider access to knowledge in a critical area of health that affects millions worldwide. Despite earning a Q4 categorization in 2023 within its relevant quartile ranks and being positioned at the 7th percentile among its peers in Scopus’ Endocrinology, Diabetes, and Metabolism rankings, the journal actively contributes to the dialogue on osteoporosis, covering essential topics from pathophysiology to treatment strategies. Researchers and professionals can access its contents freely, promoting collaboration and innovation in this dynamic field of study. With an ISSN of 2147-2653, this journal continues to pave the way for improved understanding and management of osteoporosis, making it a cornerstone publication for both seasoned experts and emerging scholars in Turkey and beyond.

Actualizaciones en Osteología is a peer-reviewed academic journal dedicated to the dissemination of pivotal research in the field of osteoporosis and mineral metabolism. Published by ASOCIACIÓN ARGENTINA DE OSTEOLOGÍA & METABOLISMO MINERAL, this journal serves as a vital resource for professionals, researchers, and students in medicine, particularly within the subdomains of endocrinology, orthopedics, and radiology. With its ISSN 1669-8975 and E-ISSN 1669-8983, the journal has been operational since 2009 and is located in Córdoba, Argentina. Its increasing relevance is underscored by its categorization in the Q4 quartile across multiple medical disciplines, indicating a committed effort to enhance knowledge in these areas. Although it operates without an open-access model, the journal provides critical insights and updates that are making a significant impact in the evolving landscape of osteology and related fields. By participating in the discussions presented, contributors and readers alike can stay abreast of the latest innovations and research findings in bone health.

Acta Otorrinolaringologica Espanola, published by Elsevier Espana SLU, is a leading journal in the field of Otorhinolaryngology, dedicated to advancing the understanding and treatment of ear, nose, and throat disorders. With a history dating back to 1973 and an established reputation for rigorously peer-reviewed research, this journal plays a pivotal role in disseminating significant findings to both clinicians and researchers. Although it is currently categorized in the Q3 quartile for 2023, ranking 72 out of 123 in its field, it serves as a vital platform for the exploration of innovative concepts and clinical practices, contributing to a deeper understanding of otolaryngological issues. While the journal is not open access, it continues to attract a wide readership due to its comprehensive articles and impactful studies. Positioned in Barcelona, Spain, this journal provides a critical resource for professionals and scholars aiming to enhance their knowledge and improve clinical outcomes in Otorhinolaryngology.

Bone & Joint Research is a prestigious open access journal published by the British Editorial Society of Bone & Joint Surgery, which has been serving the orthopedic and surgical community since its inception in 2012. With an impact factor reflecting its high standards and relevance within the field, this journal boasts impressive Scopus rankings, positioning it in the Q1 category for both Orthopedics and Sports Medicine and Surgery as of 2023. Located in the United Kingdom, the journal aims to disseminate cutting-edge research, clinical studies, and innovative approaches to treatment in musculoskeletal health, making it an indispensable resource for researchers, healthcare professionals, and students alike. The journal encourages a collaborative discourse that fosters advancements in the understanding and treatment of bone and joint diseases, fulfilling its mission to enhance patient outcomes and improve the quality of care.